CONNECT WITH US
HealthTech

HealthTech

Knit Health CEO on the AI startup building healthcare’s connective tissue

Healthcare Dive logo

Published on

Add as a preferred source on Google
Knit Health CEO on the AI startup building healthcare’s connective tissue

Knit announced a $35 million Series A this month — money that will accelerate the commercialization of the startup’s healthcare world model. Lots of hospitals are interested, Jonathan Kolstad said.

U.S. medicine is among the most advanced in the world, fueling breakthroughs in precision gene therapies, robotic surgeries, cutting-edge devices, organ transplants and more. But healthcare infrastructure lags woefully behind. Patients face long waits and steep price tags that can make even the most basic care feel out of reach.

If you ask Jonathan Kolstad, a health economist and the co-founder and CEO of Knit Health, this is a matching problem.

The issue isn’t the system’s capacity or capabilities. It’s the system’s inability to get the right patient to the right care at the right time, Kolstad told Healthcare Dive in an interview at the HLTH conference in Las Vegas.

Knit is building a healthcare world model — an AI that understands the complex dynamics of the clinical ecosystem — on the bet that there’s a big market for a system that can predict patients’ needs and direct their medical journey.

The startup, which was launched out of the University of California, Berkeley, last year, announced a $35 million Series A round on Monday — financing that will accelerate the commercial deployment of its AI model, Med-BEAM, which has been trained on a whopping 140 million patient records.

Healthcare Dive sat down with Kolstad at HLTH to talk about why healthcare needs world models, hospital demand for the technology and how Knit is differentiated in the competitive AI space.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.